PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of behbrainBioMed CentralBiomed Central Web Sitesearchsubmit a manuscriptregisterthis articleBehavioral and Brain Functions : BBFJournal Front Page
 
Behav Brain Funct. 2008; 4: 54.
Published online Nov 24, 2008. doi:  10.1186/1744-9081-4-54
PMCID: PMC2607297
Behavioral phenotypes of impulsivity related to the ANKK1 gene are independent of an acute stressor
Melanie J White,corresponding author1 C Phillip Morris,1 Bruce R Lawford,1,2 and Ross McD Young1
1Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Brisbane, Queensland 4059, Australia
2Department of Psychiatry, Royal Brisbane and Women's Hospital, Butterfield Street, Herston, Brisbane, Queensland 4029, Australia
corresponding authorCorresponding author.
Melanie J White: m2.white/at/qut.edu.au; C Phillip Morris: p.morris/at/qut.edu.au; Bruce R Lawford: Bruce_Lawford/at/health.qld.gov.au; Ross McD Young: rm.young/at/qut.edu.au
Received September 12, 2008; Accepted November 24, 2008.
Background
The A1 allele of the ANKK1 TaqIA polymorphism (previously reported as located in the D2 dopamine receptor (DRD2) gene) is associated with reduced DRD2 density in the striatum and with clinical disorders, particularly addiction. It was hypothesized that impulsivity represents an endophenotype underlying these associations with the TaqIA and that environmental stress would moderate the strength of the gene-behavior relationship.
Methods
TaqIA genotyping was conducted on 72 healthy young adults who were randomly allocated to either an acute psychosocial stress or relaxation induction condition. Behavioral phenotypes of impulsivity were measured using a card-sorting index of reinforcement sensitivity and computerized response inhibition and delay discounting tasks.
Results
Separate analyses of variance revealed associations between the A1 allele and two laboratory measures of impulsivity. The presence of the TaqIA allele (A1+) was associated with slower card-sorting in the presence of small financial reinforcers, but was overcome in a second administration after either a five-minute rest or psychosocial stress induction. A1+ participants also demonstrated significantly poorer response inhibition and faster response times on a computerized stop inhibition task, independent of acute stress exposure.
Conclusion
These findings indicate the A1 allele is associated with an endophenotype comprising both a "rash impulsive" behavioral style and reinforcement-related learning deficits. These effects are independent of stress.
The phenotypes of multiple psychiatric disorders involve features of impulsivity including attention deficit hyperactivity disorder (ADHD), bipolar disorder, mania, bulimia nervosa, several personality disorders, schizophrenia and substance dependence [1]. Impulsivity is also implicated in several forms of aggression and violence, sexual impulsivity, binge eating, obesity, self-harm and suicidal behavior [2]. As such, the study of factors that may contribute to impulsivity is fundamental to understanding and treating maladaptive human behavior.
Dopamine is integral to leading theories of an impulsive personality phenotype [3,4] and plays a crucial role in brain reinforcement circuits [2,5]. Personality theories of impulsivity also consistently emphasize the role of genetics, reflecting evidence from twin studies of high heritability on self-report measures, including sensation seeking (55% [6]), novelty seeking (40% [7]) and "rash/unplanned" impulsivity (15–40% [8]). Subsequently, genes associated with brain dopaminergic activity have been commonly studied candidates. The presence of the A1 allele of the TaqIA polymorphism (rs1800497) in the ANKK1 gene [9] (i.e., A1A1 and A1A2 genotypes) has been associated with reduced D2 dopamine receptor (DRD2) density in key structures linked to brain reinforcement, particularly in the striatum. This association has been confirmed by both in vitro [10,11] and in vivo positron emission tomography (PET) studies [12,13]. The TaqIA had been historically described as residing in the D2 dopamine receptor (DRD2) gene but has more recently been referred to as being within the ANKK1 [9]. In addition to these biological associations, a strong body of evidence suggests the involvement of the A1 allele in a range of behavioral disorders characterized by impulsivity, including severe alcohol and other substance abuse, obesity, pathological gambling and ADHD [14-16]. While A1 allele prevalence has been found to differ between ethnic populations [17], raising the issue of population stratification effects, research has shown that even across diverse ethnic groups there are still robust associations of the TaqIA with behavior [18]. Associations with addictive disorders have led to the hypothesis that ANKK1 is a reinforcement gene and those with the A1 allele are more likely to manifest brain reinforcement mechanism deficits than those without this allele [2,5]. Specifically, it is suggested that in an effort to compensate for inherited dopaminergic system deficiencies, individuals may seek to stimulate the mesocorticolimbic circuits and experience heightened reinforcement related to behaviors that increase brain dopamine levels (such as substance use), contributing to impulsive behavior. More direct evidence in rats supports an association between reduced D2 receptor availability in the ventral striatum and trait reinforcer-oriented impulsivity [19].
In behavioral genetics, simple Mendelian genetic influences are rare, with most traits reflecting the interplay of genes and environment [20]. In particular, the ANKK1 conferred risk appears to be conveyed via an interaction of A1 allelic risk and environmental stress [21-25]. For example, in a sample of alcoholic patients, negative life events and a harm avoidant personality were associated with severity of alcohol dependence in those carrying the A1 allele (A1+) but not in A1- patients [23]. Acute environmental stress is associated with impulsive behavior [26-28] and can increase dopamine neurotransmission in humans [29]. Further, recent PET scan findings suggest acute stress-induced striatal dopamine release may be greater in individuals at risk of psychosis. A significant decrease in [11C]raclopride binding potential (indicative of dopamine release), particularly in the ventral striatum, was reported for seven healthy students identified as at risk for psychosis due to elevated scores for physical anhedonia/negative schizotypy. In contrast, no such effect was found for 10 controls and 9 healthy adults scoring highly on perceptual aberrations/positive schizotypy [30]. No previous study has examined the combined influence of specific polymorphisms related to brain dopamine activity and acute stress, as a gene-environment interaction, on impulsivity.
We designed a study to examine the complexity of the ANKK1 gene-environment interaction on impulsive behavior by testing acute stress as a plausible environmental factor in this relationship. To reduce the influence of potential confounds associated with psychopathology, we studied a community sample of young adults screened for psychiatric illness. Consistent with the multidimensional nature of impulsivity [31] the laboratory paradigm incorporated three separate measures of impulsivity, assessing reinforcer-cued approach, delay discounting and response disinhibition respectively. These three dimensions are supported by the results of factor analytic studies [32] and neuroimaging research linking these to differential brain activation patterns in areas connected to mesolimbic dopamine circuits. Reinforcement-related processing and delay discounting are linked to greater activation in the ventral striatum [33], while response inhibition is associated with orbitofrontal circuit activity [34]. We directly examined the relationship between the A1 allele, laboratory-induced acute psychosocial stress and laboratory measures of impulsive behavior.
Participants
The study was approved by the Queensland University of Technology Human Research Ethics Committee (Reference 3459H). All participants (44 females and 29 males) provided signed informed consent. Participants (M = 19.29 years, SD = 1.89) were recruited from technical college campuses through advertising. Potential participants were screened at initial contact via self-report for inclusion criteria: 17 to 25 years old, no history of head injury or psychiatric disorder, no current gum disease and sufficient English language to complete the questionnaires.
Of the 73 participants, 51 (69.9%) were Australian-born and 51 (69.9%) were of Caucasian/European ethnicity, with 6 (8.2%) reporting Polynesian ethnicity, 5 (6.8%) Asian ethnicity, 1 (1.4%) Aboriginal and/or Torres Strait Islander ethnicity and 9 (12.3%) reporting 'Other' ethnicity. On the highest level of education attained, 60 (82.2%) participants reported completing high school. Seven (9.6%) participants reported a forensic history, typically involving minor offences. Despite prior screening criteria, 2 (2.7%) participants reported a history of head injury in the demographic questionnaire, and 8 (11.0%) reported a history/prior diagnosis of a psychiatric disorder. However, all participants were assessed as having normal cognitive function by the Trail Making Test [35] and an absence of psychiatric symptoms according to the General Health Questionnaire-28 [36]. On this basis, their data were retained and used in subsequent analyses.
Procedure
Participants were randomly allocated to either an experimental stress induction (preparation period for a video-taped speech) or relaxation induction condition (listening to relaxing music), with each induction lasting five minutes. This experimental manipulation consistently increases subjective feelings of stress and accompanying neuroendocrine and cardiovascular responses [37-39]. The experiment was conducted individually in order to maximize the effect of the psychosocial stressor and minimize social support confounds [40]. Specifically, those in the acute stress condition were told they were to spend the next five minutes preparing a speech on their least favorite body part which may be videotaped at the end of the testing session. These instructions are similar to those used successfully in previous research on the effect of alcohol on psychological stress [41,42] and the effect of psychosocial stress on decision-making performance [43]. A video camera was positioned on a tripod and visibly connected to the power supply in full view of the participant.
A behavioral measure of reinforcement sensitivity, the Card Arranging Reward Responsiveness Objective Test (CARROT) [44], was administered before and after the induction. This is a simple card-sorting task that measures over four trials the extent to which participants increase their speed of performance when reinforced via small financial rewards compared with non-reinforcement trials (see Table Table11 for further details). The CARROT has sound validity as a behavioral measure of Gray's reinforcement sensitivity, with scores correlating with self-reported "reward sensitivity" in an Australian university sample [45]. Measures of state anxiety (State Trait Anxiety Inventory – State form, STAI-S) [46] and feelings of relaxation or stress via a 100 mm Visual Analogue Scale (VAS) measure were also administered pre and post. Participants were screened for psychopathology (General Health Questionnaire-28) [36] and adequate cognitive function (Trail Making Test) [35]. After questionnaire completion participants provided mouth swabs. Two computerized impulsivity tasks were administered after the induction and second CARROT administration. These were a forced-choice delay discounting task (choices paired with smaller, sooner-obtained point reinforcers vs. larger, longer delayed point reinforcers) named the Two Choice Impulsivity Paradigm (TCIP) [31] followed by a stop signal task assessing the ability to withhold a prepotent response, the GoStop task [31]. Due to the nature of the scoring of these tasks and the potential influence of carry-over practice effects, they could only be administered post-induction. Table Table11 provides further detail on these behavioral measures of impulsivity.
Table 1
Table 1
Procedure: Tests of behavioral impulsivity
TaqIA Genotyping
Buccal mucosa cells were collected using Cytosoft brushes (Medical Packing Corporation, California, USA). Mouth swabs were used to obtain DNA samples to avoid a selective exclusion of participants with blood and injection phobias. These cells were spun and DNA was extracted from leucocytes using standard techniques and subsequently used as a template for determination of genotypes [47]. ANKK1 TaqIA genotyping was performed by restriction fragment length polymorphism (RFLP) analysis of PCR products. A genomic sequence of 501 bp of the coding region of ANKK1 was amplified by PCR using the forward primer 5'-GCACGTGCCACCATACCC-3' and the reverse primer 5'-TGCAGAGCAGTCAGGCTG-3'. A total of 5–10 ng of genomic DNA was amplified in a PCR master mix containing 0.2 μM of forward primer and 0.2 μM of reverse primer, 1× PCR buffer, 1.5 mM MgCl2, 200 μM dNTPs and 1 unit of Platinum Taq DNA Polymerase (Invitrogen) in a 25 μL volume. Amplification conditions were: Step 1: 94°C for 4 min, Step 2: 94°C for 30 s, Step 3: 68°C for 30 s, Step 4: 72°C for 30 s, Steps 2–4 were repeated by 40 cycles followed by 72°C for 3 min. Amplified PCR fragments were digested with TaqI restriction enzyme (New England Biolabs) and digested fragments were visualized via agarose gel electrophoresis.
TaqIA genotyping identified 45 (61.6%) participants as A2/A2 genotype (i.e., A1- allelic status), 24 (32.9%) as A1/A2 genotype and 4 (5.5%) as A1/A1 genotype (with the latter two genotypes classified as A1+ allelic status). These frequencies are in Hardy-Weinberg equilibrium, χ2(N = 73) = 0.11, p > 0.05. Subsequent analyses were performed comparing presence or absence of the A1 allele (A1+ vs. A1-). The gender and ethnicity distribution for these two genotypes are presented in Table Table2.2. Chi-square analyses using Fisher's Exact Test showed no significant associations of allelic status (A1+ vs. A1-) with gender (p = 0.33) or with ethnicity (Caucasian vs. non-Caucasian, p = 0.999). Further, there were no significant main or interactive effects of gender or ethnicity (Caucasian vs. non-Caucasian) with genotype on the baseline impulsivity measure tested, p > 0.05.
Table 2
Table 2
ANKK1 TaqIA A1 allele classificationa frequencies (% of total) by self-reported gender and ethnicity
Data Analyses
This experimental design was mixed (Time: pre, post × Genotype: A1A1 and A1A2 vs. A2A2 genotypes × Induction: stress, rest), with time as repeated measures for the CARROT only (and for manipulation checks involving the STAI and VAS measures). A square root transformation corrected a significant positive skew on TCIP mean choice latency for immediate reinforcers. Separate analyses of variance were conducted for each dependent variable of each task. While only pertinent results are reported, the full results of all analyses are available from the author.
Experimental manipulation checks
Manipulation checks via paired t-tests on pre- and post-induction STAI-S scores confirmed the validity of the induction. Those exposed to the stress induction reported significantly more anxiety after exposure (M = 40.67, SD = 12.17) than at baseline (M = 36.78, SD = 10.75), t(35) = -2.50, p = 0.017. Those exposed to the relaxation induction significantly reduced their anxiety scores from baseline (M = 37.35, SD = 11.72) to post-induction (M = 31.24, SD = 8.15), t(36) = 4.59, p < 0.001. Further tests revealed no baseline differences between the two induction groups, t(71) = 0.22, p = 0.83, and no effect of TaqIA genotype on anxiety scores at baseline or over time (p > 0.05). These test results were replicated using the VAS measure of stress, further supporting the validity of the stress manipulation.
Tobacco smoking status confound check
A self-report measure of tobacco smoking showed 27 (37.0%) of the sample were current smokers. A chi-square analysis of smoking status by TaqIA allelic status by induction condition using Fisher's exact Test showed no significant association of smoking status with allelic status for either the rest induction (p = 0.9999) or stress induction (p = 0.50) groups.
Correlations between impulsivity measures
Table Table33 presents the intercorrelations between the three laboratory paradigms used to measure impulsivity, namely the CARROT, TCIP and GoStop task variables. As shown, correlations between the three paradigms are all low, supporting their relative independence.
Table 3
Table 3
Intercorrelations between laboratory measures of impulsivity
Reinforcement sensitivity: CARROT scores
A Genotype × Induction × Time split-plot ANOVA revealed a multivariate two-way interaction between time and genotype on CARROT scores, F(1,69) = 5.41, p = 0.023, ηp2 = 0.073. Further comparisons revealed that at baseline, A1+ participants were slower in card sorting under reinforcement conditions versus non-reinforcement conditions, compared with A1- participants, F(1,71) = 6.98, p = 0.010, ηp2 = 0.089. These CARROT scores improved for A1+ participants after exposure to either induction (F(1,71) = 16.02, p < 0.001, ηp2 = 0.184), but not for A1- participants (F(1,71) = .62, p = 0.43, ηp2 = 0.009) (Figure (Figure1).1). There were no interactive or main effects of the stress manipulation (p > 0.05).
Figure 1
Figure 1
Reward sensitivity (CARROT scores) pre- and post-induction (rest vs. stress) by ANKK1 TaqIA allelic status (A1+ vs. A1-). Error bars display ± 2 SEM.
Delay discounting: TCIP measures
Separate Genotype × Induction between-groups ANOVAs were conducted for TCIP measures, proportion of smaller sooner 'immediate' reinforcer choices made and square root transformed mean response latencies for 'immediate' reinforcer selections (Table (Table4).4). There were no significant effects of allelic status or the stress manipulation (p > 0.05).
Table 4
Table 4
TCIP Delay Discounting by ANKK1 TaqIA genotype and induction condition (Rest A1+ n = 11, A1- n = 25; Acute Stress A1+ n = 17, A1- n = 18)
Inhibitory control: GoStop measures
We examined the interaction and main effects of the A1 allele and stress exposure via separate mixed-design ANOVAs for the two indices of rash impulsiveness, poorer stop inhibition and faster mean response latencies when responding to the stop signal. Mean latency data at 50 ms SOA (stimulus onset asynchrony) contained 21% missing data (15 participants successfully inhibited the prepotent response 100% of the time) and was thus excluded from analysis. For both measures, main effects of TaqIA genotype emerged, with A1+ participants demonstrating poorer stop inhibition (F(1,68) = 4.22, p = 0.04, ηp2 = 0.058) and quicker mean latencies on stop trials (F(1,66) = 9.45, p = 0.003, ηp2 = 0.125) than A1- participants across all SOAs (Figure (Figure2).2). Again, there were no interactive or main effects of the stress manipulation (p > 0.05). There were consistent effects of SOA on both response inhibition (F(4,66) = 90.52, p < 0.001, ηp2 = 0.80) and mean stop response latency (F(2,65) = 288.69, p < 0.0001, ηp2 = 0.90), with poorer stop inhibition and faster incorrect responses as SOA increased.
Figure 2
Figure 2
(A) Stop inhibition (%) and (B) mean response latency on stop trials (ms) of ANKK1 TaqIA allelic groups (A1+ vs. A1-), as a function of stimulus onset asynchrony (SOA, ms) of the stop signal.
Our study has, for the first time, examined several behavioral measures of impulsivity in combination with molecular genetic risk and acute psychosocial stress. We have shown that the TaqIA A1 allele is associated with preclinical behavioral risk in two dimensions of impulsivity, one characterized by impaired performance sensitive to reinforcers in the environment (though quickly overcome with repeated exposure) and the other by an accelerated and disinhibited approach style in the absence of incentive cues. This shared genetic risk was not associated with acute stress and may represent indirect evidence of a common etiology involving altered brain dopaminergic activity, consistent with reward deficiency theory [2,5].
Similar reinforcement-related performance deficits associated with A1+ allelic status have been previously reversed under the influence of the dopamine agonist, bromocriptine [48]. While an acute stressor can increase dopamine neurotransmission in humans [29], our study has shown a baseline performance deficit and subsequent improvement for A1+ participants regardless of acute stress. These results may reflect the importance of dopaminergic activity in the reinforcement pathways for initial CARROT performance and an increased sensitivity of those with deficiencies conferred by the A1 allele to repeated cue exposure. The second finding of poorer response inhibition by A1+ participants has been shown in Spanish alcohol dependent male patients [49]. Our extension of these findings to a non-clinical sample comprising both male and female young adults provides strong support for an association of the A1 allele with an impulsive endophenotype, rather than as a confound with alcoholism. The combined rash impulsive profile shown on this task by A1+ young adults is also similar to that shown previously for adults diagnosed with ADHD, a disorder characterized by impulsivity [50].
We suggest the A1 allele confers a greater need for practice to overcome inherent reinforcement-related learning deficits associated with fewer dopamine receptors in key brain reinforcement sites. Once sensitized, the general acceleration of approach behavior may be associated with reduced inhibitory control observed in A1+ participants. Slower baseline approach in the presence of financial reinforcers could alternatively reflect an attentional bias towards reinforcement cues in the environment, thus indicating heightened reinforcement sensitivity in these individuals. This alternative is consistent with reward deficiency [2,5].
The absence of TaqIA effects on implicit delay discounting contrasts with the impulsive profile suggested by effects on the other two behavioral measures. This may reflect a distinction between implicit and explicit awareness of reinforcers, given a contrasting recent report of an association between the A1 allele and an explicit delay discounting paradigm in an unselected university sample [51]. Future research should further examine a comparison between explicit and implicit cognitive processes with the A1 allele.
The absence of an effect of the acute psychosocial stressor on the ANKK1 TaqIA-impulsivity relationship, despite a significant increase in subjective anxiety, underscores the importance of the ANKK1 main effect on impulsivity. Further, while our results need to be replicated with a larger sample, they show that acute psychosocial stress is an unlikely explanation of why some individuals with the A1 allele exhibit impulsive tendencies. The addition of physiological and neuroendocrine stress measurement in future research is important. Future research should also investigate other plausible environmental moderators and mediators of this relationship, including chronic stress.
Conclusion
Our findings have helped elucidate the nature of an impulsivity endophenotype associated with the A1 allele of the ANKK1 TaqIA polymorphism that is differentially related to a rash impulsive behavioral style and reinforcement-related performance deficits. This phenotype is unaffected by acute stress exposure.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
MW participated in the design of the study and coordination, carried out the experiments, performed the statistical analyses and drafted the manuscript as part of a PhD thesis. CM participated in the design and coordinated the DNA extraction and genotyping. BL participated in the design. BL and CM were PhD co-supervisors. RY participated in the design and coordination, helped to draft the manuscript and was primary PhD supervisor. All authors read and approved the final manuscript.
Acknowledgements
Supported by an Australian Postgraduate Award (MW) and Institute of Health and Biomedical Innovation Postgraduate Award (MW). We thank Donald M. Dougherty for providing the software for the delay discounting and stop inhibition tasks. We also thank Christopher D. Swagell and Adelene Liao for assistance with genotyping.
  • American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 4. Washington, DC: American Psychiatric Press; 1994.
  • Blum K, Braverman ER, Holder JM, Lubar JF, Monastra VJ, Miller D, Lubar JO, Chen TJH, Comings DE. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J Psychoactive Drugs. 2000;32 Suppl:i–iv. [PubMed]
  • Gray JA, McNaughton N. The Neuropsychology of Anxiety: An Enquiry into the Functions of the Septo-hippocampal System. 2. New York: Oxford University Press; 2000.
  • Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry. 1993;50:975–990. [PubMed]
  • Noble EP. Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review. Eur Psychiatry. 2000;15:79–89. doi: 10.1016/S0924-9338(00)00208-X. [PubMed] [Cross Ref]
  • Hur Y, Bouchard TJ., Jr The genetic correlation between impulsivity and sensation seeking traits. Behav Genet. 1997;27:455–463. doi: 10.1023/A:1025674417078. [PubMed] [Cross Ref]
  • Heath AC, Cloninger CR, Martin NG. Testing a model for the genetic structure of personality: a comparison of the personality systems of Cloninger and Eysenck. J Pers Soc Psychol. 1994;66:762–775. doi: 10.1037/0022-3514.66.4.762. [PubMed] [Cross Ref]
  • Eysenck HJ. A biometrical-genetical analysis of impulsive and sensation seeking behaviour. In: Zuckerman M, editor. Biological bases of sensation seeking, impulsivity and anxiety. New Jersey: Erlbaum; 1983. pp. 1–27.
  • Neville MJ, Johnstone EC, Walton RT. Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat. 2004;23:540–545. doi: 10.1002/humu.20039. [PubMed] [Cross Ref]
  • Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ. Allelic association of the D2 dopamine receptor gene with receptor binding characteristics in alcoholism. Arch Gen Psychiatry. 1991;48:648–654. [PubMed]
  • Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry EK, Morris CM, Perry RH, Ferrier IN, Court JA. D2 dopamine receptor gene (DRD2) TaqI A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics. 1997;7:479–484. doi: 10.1097/00008571-199712000-00006. [PubMed] [Cross Ref]
  • Pohjalainen T, Rinne JO, Nagren K, Lehikoinen P, Anttila K, Syvalahti EKG, Hietala J. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry. 1998;3:256–260. doi: 10.1038/sj.mp.4000350. [PubMed] [Cross Ref]
  • Jonsson EG, Nothen MM, Grunhage F, Farde L, Nakashima Y, Propping P, Sedvall GC. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry. 1999;4:290–296. doi: 10.1038/sj.mp.4000532. [PubMed] [Cross Ref]
  • Noble EP. D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet. 2003;116:103–125. doi: 10.1002/ajmg.b.10005. [PubMed] [Cross Ref]
  • Bobb AJ, Castellanos FX, Addington AM, Rapoport JL. Molecular genetic studies of ADHD: 1991 to 2004. Am J Med Genet. 2006;141:551–565. doi: 10.1002/ajmg.b.30086. [Cross Ref]
  • Sery O, Drtilkova I, Theiner P, Pitelova R, Staif R, Znojil V, Lochman J, Didden W. Polymorphism of DRD2 gene and ADHD. Neuro Endocrinol Lett. 2006;27:236–240. [PubMed]
  • Barr CL, Kidd KK. Population frequencies of the A1 allele at the dopamine D2 receptor locus. Biol Psychiatry. 1993;34:204–209. doi: 10.1016/0006-3223(93)90073-M. [PubMed] [Cross Ref]
  • Young RM, Lawford BR, Nutting A, Noble EP. Advances in molecular genetics and the prevention and treatment of substance misuse: implications of association studies of the A1 allele of the D2 dopamine receptor gene. Addict Behav. 2004;29:1275–1294. doi: 10.1016/j.addbeh.2004.06.012. [PubMed] [Cross Ref]
  • Dalley JW, Fryer TD, Brichard L, Robinson ESJ, Theobald DEH, Laane K, Pena Y, Murphy ER, Shah Y, Probst K, Abakumova I, Aigbirhio FI, Richards HK, Hong Y, Baron J-C, Everitt BJ, Robbins TW. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science. 2007;315:1267–1270. doi: 10.1126/science.1137073. [PMC free article] [PubMed] [Cross Ref]
  • Caspi A, Moffitt TE. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nature Rev Neurosci. 2006;7:583–590. doi: 10.1038/nrn1925. [PubMed] [Cross Ref]
  • Young RM, Lawford BR, Noble EP, Kann B, Wilkie A, Ritchie T, Arnold L, Shadforth S. Harmful drinking in military veterans with post-traumatic stress disorder: association with the D2 dopamine receptor A1 allele. Alcohol Alcohol. 2002;37:451–456. [PubMed]
  • Berman SM, Noble EP. The D2 dopamine receptor (DRD2) gene and family stress: interactive effects on cognitive functions in children. Behav Genet. 1997;27:33–43. doi: 10.1023/A:1025611208475. [PubMed] [Cross Ref]
  • Bau CH, Almeida S, Hutz MH. The TaqI A1 allele of the dopamine D2 receptor gene and alcoholism in Brazil: association and interaction with stress and harm avoidance on severity prediction. Am J Med Genet. 2000;96:302–306. doi: 10.1002/1096-8628(20000612)96:3<302::AID-AJMG13>3.0.CO;2-I. [PubMed] [Cross Ref]
  • Madrid GA, MacMurray J, Lee JW, Anderson BA, Comings DE. Stress as a mediating factor in the association between the DRD2 TaqI polymorphism and alcoholism. Alcohol. 2001;23:117–122. doi: 10.1016/S0741-8329(00)00138-5. [PubMed] [Cross Ref]
  • Erblich J, Lerman C, Self DW, Diaz GA, Bovbjerg DH. Stress-induced cigarette craving: effects of the DRD2 TaqI RFLP and SLC6A3 VNTR polymorphisms. Pharmacogenomics J. 2004;4:102–109. doi: 10.1038/sj.tpj.6500227. [PubMed] [Cross Ref]
  • Bogdan R, Pizzagalli DA. Acute stress reduces reward responsiveness: implications for depression. Biol Psychiatry. 2006;60:1147–1154. doi: 10.1016/j.biopsych.2006.03.037. [PMC free article] [PubMed] [Cross Ref]
  • Conner KR, Phillips MR, Meldrum S, Knox KL, Zhang Y, Yang G. Low-planned suicides in China. Psychol Med. 2005;35:1197–204. doi: 10.1017/S003329170500454X. [PubMed] [Cross Ref]
  • Roberti JW. Sensation seeking characteristics and neuroendocrine responses to an acute psychological challenge for undergraduates with career interests in forensic sciences. Internet J Forensic Sci. 2003;1:1–22.
  • Pruessner JC, Champagne F, Meaney MJ, Dagher A. Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride. J Neurosci. 2004;24:2825–2831. doi: 10.1523/JNEUROSCI.3422-03.2004. [PubMed] [Cross Ref]
  • Soliman A, O'Driscoll GA, Pruessner J, Holahan ALV, Boileau I, Gagnon D, Dagher A. Stress-induced dopamine release in humans at risk of psychosis: a [C-11]raclopride PET study. Neuropsychopharmacology. 2008;33:2033–2041. doi: 10.1038/sj.npp.1301597. [PubMed] [Cross Ref]
  • Dougherty DM, Mathias CW, Marsh DM, Jagar AA. Laboratory behavioral measures of impulsivity. Behav Res Methods. 2005;37:82–90. [PubMed]
  • Dom G, De Wilde B, Hulstijn W, Sabbe B. Dimensions of impulsive behaviour in abstinent alcoholics. Pers Indiv Diff. 2007;42:465–476. doi: 10.1016/j.paid.2006.08.007. [Cross Ref]
  • Hariri AR, Brown SM, Williamson DE, Flory JD, de Wit H, Manuck SB. Preference for immediate over delayed rewards is associated with magnitude of ventral striatal activity. J Neurosci. 2006;26:13213–13217. doi: 10.1523/JNEUROSCI.3446-06.2006. [PubMed] [Cross Ref]
  • Horn NR, Dolan M, Elliott R, Deakin JFW, Woodruff PWR. Response inhibition and impulsivity: an fMRI study. Neuropsychologia. 2003;41:1959–1966. doi: 10.1016/S0028-3932(03)00077-0. [PubMed] [Cross Ref]
  • Spreen O, Strauss E. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. 2. New York: Oxford University Press; 1998.
  • Goldberg D, Williams P. A User's Guide to the General Health Questionnaire. Berkshire: NFER-NELSON Publishing; 1988.
  • Kirschbaum C, Pirke KM, Hellhammer DH. The Trier Social Stress Test: a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology. 1993;28:76–81. doi: 10.1159/000119004. [PubMed] [Cross Ref]
  • Feldman PJ, Cohen S, Hamrick N, Lepore SJ. Psychological stress, appraisal, emotion and cardiovascular response in a public speaking task. Psychol Health. 2004;19:353–368. doi: 10.1080/0887044042000193497. [Cross Ref]
  • Elsenbruch S, Lucas A, Holtmann G, Haag S, Gerken G, Riemenschneider N, Langhorst J, Kavelaars A, Heijnen CJ, Schedlowski M. Public speaking stress-induced neuroendocrine responses and circulating immune cell redistribution in irritable bowel syndrome. Am J Gastroenterol. 2006;101:2300–2307. doi: 10.1111/j.1572-0241.2006.00837.x. [PubMed] [Cross Ref]
  • Thorsteinsson EB, James JE. A meta-analysis of the effects of experimental manipulations of social support during laboratory stress. Psychol Health. 1999;14:869–886. doi: 10.1080/08870449908407353. [Cross Ref]
  • Levenson RW. Alcohol and stress response dampening: pharmacological effects, expectancy, and tension reduction. J Abn Psychol. 1980;89:528–538. doi: 10.1037/0021-843X.89.4.528. [PubMed] [Cross Ref]
  • Steele CM, Josephs RA. Drinking your troubles away II: an attention-allocation model of alcohol's effect on psychological stress. J Abn Psychol. 1988;97:196–205. doi: 10.1037/0021-843X.97.2.196. [PubMed] [Cross Ref]
  • Preston SD, Tansfield RBS, Buchanan TW, Bechara A. Effects of anticipatory stress on decision making in a gambling task. Behav Neurosci. 2007;121:257–263. doi: 10.1037/0735-7044.121.2.257. [PubMed] [Cross Ref]
  • Powell J, Al-Adawi S, Morgan J, Greenwood RJ. Motivational deficits after brain injury: effects of bromocriptine in 11 patients. J Neurol Neurosurg Psychiatry. 1996;60:416–421. doi: 10.1136/jnnp.60.4.416. [PMC free article] [PubMed] [Cross Ref]
  • Kambouropoulos N, Staiger PK. Personality and responses to appetitive and aversive stimuli: the joint influence of behavioural approach and behavioural inhibition systems. Pers Indiv Diff. 2004;37:1153–1165. doi: 10.1016/j.paid.2003.11.019. [Cross Ref]
  • Speilberger CD. State-Trait Anxiety Inventory for Adults (Form Y): Sampler Set. Redwood City, California: Mind Garden; 1983.
  • Grandy DK, Zhang Y, Civelli O. PCR detection of the TaqA RFLP at the DRD2 locus. Hum Mol Genet. 1993;2:2197. doi: 10.1093/hmg/2.12.2197-a. [PubMed] [Cross Ref]
  • Kirsch P, Reuter M, Mier D, Lonsdorf T, Stark R, Gallhofer B, Vaitl D, Hennig J. Imaging gene-substance interactions: the effect of the DRD2 TaqIA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward. Neurosci Lett. 2006;405:196–201. doi: 10.1016/j.neulet.2006.07.030. [PubMed] [Cross Ref]
  • Rodriguez-Jimenez R, Ãvila C, Ponce G, Ibanez MI, Rubio G, Jimenez-Arriero MA, Ampuero I, Ramos JA, Hoenicka J, Palomo T. The TaqIA polymorphism linked to the DRD2 gene is related to lower attention and less inhibitory control in alcoholic patients. Eur Psychiatry. 2006;21:66–69. doi: 10.1016/j.eurpsy.2005.05.010. [PubMed] [Cross Ref]
  • Bekker EM, Overtoom CC, Kenemans JL, Kooij JJ, De Noord I, Buitelaar JK, Verbaten MN. Stopping and changing in adults with ADHD. Psychol Med. 2005;35:807–816. doi: 10.1017/S0033291704003459. [PubMed] [Cross Ref]
  • Eisenberg DT, Mackillop J, Modi M, Beauchemin J, Dang D, Lisman SA, Lum JK, Wilson DS. Examining impulsivity as an endophenotype using a behavioral approach: a DRD2 TaqI A and DRD4 48-bp VNTR association study. Behav Brain Funct. 2007;3:2. doi: 10.1186/1744-9081-3-2. [PMC free article] [PubMed] [Cross Ref]
Articles from Behavioral and Brain Functions : BBF are provided here courtesy of
BioMed Central